Efficacy Capital, Ltd.'s Net Worth
$0
Estimate Recalculated Sep 8, 2024 07:30PM EST
Who is Efficacy Capital, Ltd.?
Efficacy Capital, Ltd. does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include REPROS THERAPEUTICS INC., and AEOLUS PHARMACEUTICALS, INC..
SEC CIK
Efficacy Capital, Ltd.'s CIK is 0001350855
Past Insider Trading and Trends
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
REPROS THERAPEUTICS INC. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -5.79% | -156.80K |
$0.67 | -$105,702.41 | 2.55M |
Dec 17 - Dec 21
| |||
Form 4
| -12.47% | -386.10K |
$0.68 | -$264,235.10 | 2.71M |
Dec 11 - Dec 15
| |||
Form 4
| -14.88% | -541.00K |
$0.70 | -$380,553.40 | 3.1M |
Nov 30 - Dec 2
| |||
Form 4
| -15.28% | -656.00K |
$0.72 | -$471,400.40 | 3.64M |
Nov 19 - Nov 23
| |||
Form 4
| +0.26% | 11.3K |
$7.76 | $87,688.00 | 4.29M |
Oct 31
| |||
Form 4
| +0.81% | 34.29K |
$6.94 | $238,026.04 | 4.28M |
Oct 28 - Oct 29
| |||
Form 4
| +1.48% | 62.13K |
$6.72 | $417,644.13 | 4.25M |
Oct 23 - Oct 27
| |||
Form 4
| +0.72% | 30K |
$6.42 | $192,600.00 | 4.18M |
Oct 17
| |||
Form 4
| +0.73% | 30.3K |
$6.52 | $197,619.00 | 4.15M |
Oct 10 - Oct 13
| |||
Form 4
| +81.04% | 1.85M |
$6.50 | $12,000,001.00 | 4.12M |
Oct 2
| |||
Form 4
| -11.71% | -302.06K |
$9.21 | -$2,783,355.78 | 2.28M |
Mar 14 - Mar 27
| |||
Form 4
| +1.98% | 50K |
$8.50 | $425,000.00 | 2.58M |
Mar 12
| |||
Form 4
| +1.49% | 74.5K |
$8.55 | $636,135.00 | 5.06M |
Mar 7 - Mar 10
| |||
Form 4
| +2.08% | 50K |
$8.30 | $415,100.00 | 2.46M |
Feb 28 - Feb 29
| |||
Form 4
| +0.73% | 34.5K |
$9.02 | $311,460.00 | 4.79M |
Jan 4 - Jan 7
| |||
Form 4
| +5.52% | 124.1K |
$9.37 | $1,162,563.00 | 2.37M |
Dec 28 - Dec 31
| |||
Form 4
| +4.66% | 100K |
$9.45 | $944,600.00 | 2.25M |
Dec 20 - Dec 21
| |||
Form 4
| +24.64% | 85.6K |
$9.82 | $840,199.00 | 433.04K |
Dec 18 - Dec 19
| |||
Form 4
| +8.42% | 160.1K |
$9.51 | $1,522,470.00 | 2.06M |
Dec 13 - Dec 14
| |||
Form 4
| +5.51% | 99.3K |
$8.05 | $799,074.00 | 1.9M |
Dec 5 - Dec 6
| |||
Form 4
| +7.23% | 121.5K |
$8.06 | $979,490.00 | 1.8M |
Dec 3 - Dec 4
| |||
Form 4
| +31.61% | 217K |
$12.46 | $2,699,023.90 | 903.6K |
Oct 17 - Oct 25
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
AEOLUS PHARMACEUTICALS, INC. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -47.86% | -3.99M |
$0.62 | -$2,464,479.64 | 4.35M |
Mar 15 - Mar 16
| |||
Form 4
| -0.77% | -64.60K |
$0.97 | -$62,522.00 | 8.34M |
Feb 15 - Feb 16
| |||
Form 4
| -14.22% | -1.39M |
—
|
—
| 8.41M |
Jan 6 - Feb 8
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||